The American Journal of Managed Care16 天
Impact of BTK Inhibitors on Treatment Paradigm of CLL and MCL
Panelists discuss how Bruton tyrosine kinase (BTK) inhibitors have transformed the treatment paradigm for patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL ...
The American Journal of Managed Care9 天
Optimizing BTK Inhibitor Treatment: Managing Adverse Effects and Adherence
Patient-Centered Selection of BTK Inhibitors: Balancing Clinical Factors and Patient Preferences EP: 16 . Implementation of Shared Decision-Making in BTK Inhibitor Treatment ...